Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,734 | 8,508 | 6,060 | 6,046 | 6,310 |
| Operating Income | -6,734 | -8,508 | -6,060 | -6,046 | -6,310 |
| Other Income | 297 | 10 | 1,655 | 976 | -468 |
| Pre-tax Income | -6,437 | -8,498 | -4,405 | -5,070 | -6,779 |
| Income Tax | N/A | 57 | 3 | 25 | N/A |
| Net Income Continuous | -6,437 | -8,554 | -4,407 | -5,095 | -6,779 |
| Net Income | $-6,437 | $-8,554 | $-4,407 | $-5,095 | $-6,779 |
| EPS Basic Total Ops | -0.10 | -0.15 | -0.08 | -0.09 | -0.12 |
| EPS Basic Continuous Ops | -0.10 | -0.15 | -0.08 | -0.09 | -0.12 |
| EPS Diluted Total Ops | -0.10 | -0.15 | -0.08 | -0.09 | -0.12 |
| EPS Diluted Continuous Ops | -0.10 | -0.15 | -0.08 | -0.09 | -0.12 |
| EBITDA(a) | $-6,637 | $-8,409 | $-5,962 | $-5,949 | $-6,213 |